L8668

Levetiracetam

≥98% (HPLC), powder, acetylcholine receptor inhibitor

• 동의어(들): (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide, 2(S)-(2-Oxopyrrolidin-1-yl)butyramide
• 실험식(Hill 표기법): C₈H₁₄N₂O₂
• CAS Number: 102767-28-2
• Molecular Weight: 170.21
• MDL number: MFCD03265610
• UNSPSC 코드: 12352200
• PubChem Substance ID: 329817665
• NACRES: NA.77

속성

• Product Name: Levetiracetam, ≥98% (HPLC)
• Quality Level: 100
• 분석: ≥98% (HPLC)
• 양식: powder
• 색상: white
• solubility: H₂O: >5 mg/mL
• 주관자: UCB Inc.
• SMILES string: CC[C@H](N1CCCC1=O)C(N)=O
• InChI: 1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
• InChI key: HPHUVLMMVZITSG-LURJTMIESA-N
• 유전자 정보: human ... CACNA1B(774), SV2A(9900)

설명

일반 설명

Levetiracetam is a member of the pyrrolidone family, which is a second-generation anti-epileptic drug (AED). It acts as a neuroprotective and hyperalgesic drug. Levetiracetam is implicated in cholinergic neurotransmission.

애플리케이션

Levetiracetam has been used as an anti-epileptic drug to study its effects on glucose-mediated death.

생화학적/생리학적 작용

Levetiracetam is a pyrrolidine with antiepileptic activity.

Levetiracetam is a pyrrolidine with antiepileptic activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.

특징 및 장점

This compound was developed by UCB Inc.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

안전성 정보

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable
• 개인 보호 장비: dust mask type N95 (US), Eyeshields, Gloves